Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
MIXED SCLEROSING BONE DYSTROPHIES
View through CrossRef
1. A Nigerian patient with radiographic features of osteopathia striata, osteopoikilosis and melorheostosis is reported. Also radiographs of a patient from the Radiographic Museum of the Institute of Orthopaedics at the Royal National Orthopaedic Hospital are reproduced because they show a similar mixture of these conditions. 2. lt is probable that a common factor is present at some stage in the development of melorheostosis, osteopathia striata, osteopoikilosis and possibly osteopetrosis.
British Editorial Society of Bone & Joint Surgery
Title: MIXED SCLEROSING BONE DYSTROPHIES
Description:
1.
A Nigerian patient with radiographic features of osteopathia striata, osteopoikilosis and melorheostosis is reported.
Also radiographs of a patient from the Radiographic Museum of the Institute of Orthopaedics at the Royal National Orthopaedic Hospital are reproduced because they show a similar mixture of these conditions.
2.
lt is probable that a common factor is present at some stage in the development of melorheostosis, osteopathia striata, osteopoikilosis and possibly osteopetrosis.
Related Results
Poster 107: The Use of Coacervate Sustained Release System to Identify the Most Potent BMP for Bone Regeneration
Poster 107: The Use of Coacervate Sustained Release System to Identify the Most Potent BMP for Bone Regeneration
Objectives: Bone morphogenetic proteins (BMPs) belong to the transforming growth factor superfamily that were first discovered by Marshall Urist. There are 14 BMPs identified to da...
The irradiated human mandible
The irradiated human mandible
Mandibular bone is known to be susceptible to irradiation damage, especially when radiation dose exceeds 50 Gy. This can result in compromised wound healing and ultimately osteorad...
Inhibition of Calcitonin Gene-Related Peptide and Insulin-Like Growth Factor: A Potential New Therapeutic Strategy To Reduce Bone Pain in Bone Metastases of Breast Cancer.
Inhibition of Calcitonin Gene-Related Peptide and Insulin-Like Growth Factor: A Potential New Therapeutic Strategy To Reduce Bone Pain in Bone Metastases of Breast Cancer.
Abstract
Bone pain caused by bone metastases is one of the most common complications in patients with breast cancer. However, the precise molecular mechanism of bone...
P0871THE IMPACT OF ENDOGENOUS PTH/PTH1R/ATF4 AXIS ON TRABECULAR AND CORTICAL BONE REMODELING AND BONE GROWTH OF YOUNG RATS WITH EXPERIMENTAL CHRONIC KIDNEY DISEASES
P0871THE IMPACT OF ENDOGENOUS PTH/PTH1R/ATF4 AXIS ON TRABECULAR AND CORTICAL BONE REMODELING AND BONE GROWTH OF YOUNG RATS WITH EXPERIMENTAL CHRONIC KIDNEY DISEASES
Abstract
Background and Aims
Chronic kidney disease - mineral bone disorder (CKD–MBD) is one of the major clinical complications...
Abstract 1490: Elucidating the effect of glutamine metabolism in breast to bone metastasis
Abstract 1490: Elucidating the effect of glutamine metabolism in breast to bone metastasis
Abstract
Bone-metastatic lesions will develop in approximately 65-75% of patients with metastatic breast cancer and are associated with high morbidity and mortality....
Role of Mechanical Signaling in Bone Tissue
Role of Mechanical Signaling in Bone Tissue
As the global population ages and life expectancy continues to rise, osteoporosis
continues to be a growing worldwide health concern. The International
...
Pitfalls and Key Features of a Case of Sclerosing Pneumocytoma: A Cytological Challenge?
Pitfalls and Key Features of a Case of Sclerosing Pneumocytoma: A Cytological Challenge?
<b><i>Background:</i></b> The aim of the current case report is to re-evaluate the key features and pitfalls of fine-needle aspiration cytology (FNAC) in th...
P2-17-06: Patterns of Bone Density Evaluation in a Community Population Treated with Aromatase Inhibitors.
P2-17-06: Patterns of Bone Density Evaluation in a Community Population Treated with Aromatase Inhibitors.
Abstract
Aromatase inhibitors (AIs) lead to an increased risk of bone loss and fracture. Fracture rates in adjuvant AI studies have ranged from 2.3% to 11%, with hig...